Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04184973 · ClinicalTrials.gov registry record · NA
Efficacy and Safety of the CG-100 Intraluminal Bypass Device
A NA study of Rectal Cancer and Rectal/Anal, sponsored by Colospan.
- Recruiting
- Registry status
- NA
- Development phase
- 250
- Enrollment target
- 14
- Study locations
NCT04184973 is a NA study of Rectal Cancer and Rectal/Anal that is actively recruiting participants, run by Colospan. The registered enrollment target is 250 participants, below the 3,163-participant average among 70 other Rectal Cancer trials with a reported enrollment target (92% lower). The trial reports 14 study locations across 11 states.
The verdict
NCT04184973, a NA study of Rectal Cancer and Rectal/Anal, is actively recruiting participants, sponsored by Colospan.
- RECRUITING
- Registry status
- NA
- Development phase
- 250 participants
- Enrollment target
- 14
- Study locations
Study Summary
A randomized trial to assess the safety and efficacy of CG-100 for reducing stoma creation rate in subjects undergoing mesorectal excision.
Conditions Studied
Interventions
- DEVICE CG-100 intraluminal bypass device
- PROCEDURE Stoma
Study Locations (14)
Other
- Soroka University Medical Center - Beersheba
- Carmel Medical Center - Haifa
- Rabin Medical Center - Petah Tikva
California
- University of California Irvine - Orange
- Kaiser Permanente San Diego medical Center - San Diego
Colorado
- Colorado University Anschutz Medical Campus - Aurora
Kentucky
- University of Louisville - Louisville
Michigan
- Henry Ford Health System - Detroit
Minnesota
- East Bank Hospital - M Health Fairview University of Minnesota Medical Center - Minneapolis
New York
- New York-Presbyterian / Weill Cornell Medical Center - New York
Pennsylvania
- Jefferson University Hospital - Philadelphia
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 250 participants |
| Start Date | 2020-06-23 |
| Est. Completion | 2026-12-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04184973
The ClinicalTrials.gov registry entry for NCT04184973 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 250 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 3,163-participant average among 70 other Rectal Cancer trials with a reported enrollment target (92% lower). The listed sponsor is Colospan, which has 1 total studies on file at ClinicalTrials.gov.
The record links to 3 conditions, with Rectal Cancer appearing as the primary indexed condition, and to 2 interventions - of which CG-100 intraluminal bypass device is the first listed.
NCT04184973 reports 14 study locations spanning 11 distinct geographic areas - top geographies include Other, California, Colorado.
Frequently Asked Questions
What is clinical trial NCT04184973 about?
NCT04184973 is a clinical study titled "Efficacy and Safety of the CG-100 Intraluminal Bypass Device". A randomized trial to assess the safety and efficacy of CG-100 for reducing stoma creation rate in subjects undergoing mesorectal excision.
What is the current status of trial NCT04184973?
This trial is currently recruiting. It is a NA study. The enrollment target is 250 participants. The study started on 2020-06-23. Estimated completion is 2026-12-31.
What conditions does trial NCT04184973 study?
This clinical trial studies the following conditions: Rectal Cancer, Rectal/Anal, Rectal Tumor.
What interventions are being tested in trial NCT04184973?
The interventions under investigation include: CG-100 intraluminal bypass device (DEVICE), Stoma (PROCEDURE).
Who is sponsoring clinical trial NCT04184973?
This trial is sponsored by Colospan, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04184973 being conducted?
This trial has 14 study locations across California, Colorado, Kentucky, Michigan, Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Rectal Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
An Informational and Supportive Care Intervention for Patients With Locally Advanced Rectal Cancer
RECRUITING · NA
-
Ultrasound and Photoacoustic Imaging for Enhanced Differential Diagnosis of Rectal Cancer
RECRUITING · NA
-
The Radiation Oncology-Biology Integration Network (ROBIN) Molecular Characterization Trial (MCT) of Standard Short Course Radiotherapy for Rectal Cancer
RECRUITING · NA
-
Resilience and Equity in Aging, Cancer, and Health (REACH)
RECRUITING · NA
-
Improving Nutrition and Physical Activity for Cancer Survivors (Tools To Be Fit)
RECRUITING · NA
-
Evaluating a Nonessential Amino Acid Restriction (NEAAR) Medical Food With Total Neoadjuvant Therapy for Locally Advanced Rectal Cancer (LARC)
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.